EAM
KMTS

Eventide Asset Management’s Kestra Medical Technologies KMTS Stock Holding History

Eventide Asset Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.8M Buy
1,446,742
+878
+0.1% +$18.4K 0.49% 69
2026
Q1 		$28.8M Buy
1,445,864
+176,213
+14% +$4.15M 0.48% 72
2025
Q4 		$33.7M Buy
1,269,651
+65,288
+5% +$1.68M 0.53% 66
2025
Q3 		$28.6M Buy
1,204,363
+143,806
+14% +$2.57M 0.47% 80
2025
Q2 		$17.6M Buy
1,060,557
+785,557
+286% +$17.2M 0.31% 100
2025
Q1 		$6.85M Buy
+275,000
New +$6.32M 0.14% 134

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Eventide Asset Management's KMTS Position: Q2 2026 in Review

Eventide Asset Management increased its Kestra Medical Technologies (KMTS) stake by 0.06% in Q2 2026, buying an estimated $18.4K and bringing the position to 1,446,742 shares worth $36.8M. The position accounts for 0.49% of the portfolio, ranked #69.

Eventide Asset Management first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Eventide Asset Management held 1,446,742 shares of Kestra Medical Technologies worth $36.8M as of Q2 2026.
  • Eventide Asset Management bought 878 Kestra Medical Technologies shares in Q2 2026, an estimated $18.4K.
  • Kestra Medical Technologies made up 0.49% of Eventide Asset Management's portfolio in Q2 2026, its #69 holding.
  • Eventide Asset Management first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.